Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 8 results found. Search for [ Manni Kantipudi ]

Results 1 to 8 of 8
Zeba Siddiqui
Mumbai, April 15, 2015
India may go to WTO if the European Union does not reconsider its decision to suspend the sale of about 700 generic drugs that were approved based on clinical trials by GVK Biosciences, the firm said.


K Mammen Mathew
Berlin, December 10, 2014
The German drug regulator also suspended the marketing authorisation given to the drugs concerned based on the data of clinical trials supplied by GVK Biosciences.


PTI
Hyderabad, December 8, 2014
Replying to a query, company's CEO said it would cost about Rs 30 lakh to redo the studies, which the company is willing to bear on behalf of the clients.


E Kumar Sharma
December 6, 2014
\"We are clearly disappointed by the outcome and do feel it raises questions on the future viability of this business,\" Manni Kantipudi, CEO of GVK Biosciences told.


PTI
Hyderabad , November 6, 2014
The US-headquartered Vanta Bioscience offers toxicology evaluation services for pharmaceutical, biotech, food supplements and feed additives industries.


E. Kumar Sharma
January 29, 2014
Aragen is a privately held US-based, pre-clinical CRO specializing in high-value biologics services. As per the deal, GVK Bio will acquire the capital stock of Aragen Bioscience.


E. Kumar Sharma
Hyderabad, January 9, 2013
The Hyderabad-based contract research organisation has inked an agreement with US-based Onconova Therapeutics to develop new cancer drugs.


www.businesstoday.in
August 20, 2008
Call it the six-year-itch. Set up in 2002 by GVK scion G.V. Sanjay Reddy, GVK Biosciences is now talking leadership and on ways to get there quickly.


PAGES 1 OF 1